Context before claims
Scientific information is presented with its intended audience, limitations, and use boundaries made explicit.
Meet the founder
A physician-scientist and neurologist whose experience across research, medicine, and drug development shapes the standards behind the AXON ecosystem.

A career across science
Dr. Nina Jaitly is a physician-scientist and neurologist whose work has crossed federal research systems, academic medicine, pharmaceutical development, neuroimmunology, and public health.
Her background includes work within NIH research systems and medical-science leadership in neurology at Novartis, alongside training in applied epidemiology and biostatistics. That combination gives her a practical view of how evidence moves—from research design and interpretation to regulated development and public communication.
Dr. Jaitly founded AxonPeptide after observing how fragmented the category had become between academic research, pharmaceutical regulation, and growing public interest. Her response emphasized careful sourcing, documentation review, independent verification, and public-facing transparency.
Across the wider AXON ecosystem, that perspective supports distinct experiences for distinct audiences while keeping scientific context, limitations, and accountability visible.
From fragmentation to framework
Her multidisciplinary path informs a practical operating standard: understand the context, examine the documentation, and communicate the boundary.
Scientific information is presented with its intended audience, limitations, and use boundaries made explicit.
Sourcing, documentation review, traceability, and independent verification are treated as core systems—not afterthoughts.
Consumer skin care, research supply, and documentation education remain separate while reflecting one standard for responsible communication.
Founder philosophy
Dr. Jaitly’s leadership approach connects scientific rigor with communication people can navigate—without blurring the line between research information and individualized medical care.
Start a conversation
For interviews, podcasts, panels, educational sessions, or other speaking opportunities, use the media and speaking inquiry route.